documents: FDA-2016-N-0124-0105

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2016-N-0124-0105 FDA FDA-2016-N-0124 Reference 61 - FDA Guideline for Industry, M3(R2) Nonclinical Safety Studies for the Conduct of Human Clinical Trials re Safety and Effectiveness of Consumer Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use; Proposed Amendment of the Tentative Final Monograph; Reopening of Administrative Record Supporting & Related Material Background Material 2016-06-30T04:00:00Z 2016 6     2016-06-30T15:31:21Z   0 0 09000064820750f9

Links from other tables